Official Journal of the European Union

C series

—

C/2025/4151

(Case T-222/23)

(Access to documents - Regulation (EC) No 1049/2001 - Documents relating to the procedure for renewing the approval of the active substance captan - EFSA decision to disclose the full list of co-formulants present in the formulation for representative uses of the plant protection product Captan 80 WG referring to that substance - Exception relating to the protection of the commercial interests of a natural or legal person - Overriding public interest - Regulation (EC) No 1367/2006 - Information relating to emissions into the environment)

(C/2025/4151)

Language of the case: English

Parties

Applicant: Arysta Lifescience (Noguères, France) (represented by: D. Abrahams and Z. Romata, lawyers)

Defendant: European Food Safety Authority (represented by: D. Detken, S. Gabbi and C. Pintado, acting as Agents, and by S. Raes, E. Kairis and Z. Lejeune, lawyers)

Interveners in support of the defendant: Claude Gruffat (Mulsans, France), Benoît Biteau (Sablonceaux, France) (represented by B. Kloostra, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the European Food Safety Authority (EFSA) of 17 February 2023 notifying it of its decision to disclose fully, on 3 March 2023, the list of co-formulants present in the formulation for representative uses of the plant protection product Captan 80 WG submitted in the framework of the renewal of the approval of the active substance captan.

Operative part of the judgment

The Court:

Dismisses the action;

Orders Arysta Lifescience to bear its own costs and to pay those incurred by the European Food Safety Authority (EFSA) and by Mr Claude Gruffat and Mr Benoît Biteau, including EFSA’s costs relating to the proceedings for interim relief.

—

(1)

OJ C 252, 17.7.2023.

—

ELI: http://data.europa.eu/eli/C/2025/4151/oj

ISSN 1977-091X (electronic edition)

—